Jennifer A Clancy1, David A Mary1, Klaus K Witte1, John P Greenwood1, Susan A Deuchars2, Jim Deuchars3. 1. School of Medicine, University of Leeds, Leeds LS2 9JT, UK. 2. School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UK. 3. School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UK. Electronic address: J.Deuchars@leeds.ac.uk.
Abstract
BACKGROUND: Vagus nerve stimulation (VNS) is currently used to treat refractory epilepsy and is being investigated as a potential therapy for a range of conditions, including heart failure, tinnitus, obesity and Alzheimer's disease. However, the invasive nature and expense limits the use of VNS in patient populations and hinders the exploration of the mechanisms involved. OBJECTIVE: We investigated a non-invasive method of VNS through electrical stimulation of the auricular branch of the vagus nerve distributed to the skin of the ear--transcutaneous VNS (tVNS) and measured the autonomic effects. METHODS: The effects of tVNS parameters on autonomic function in 48 healthy participants were investigated using heart rate variability (HRV) and microneurography. tVNS was performed using a transcutaneous electrical nerve stimulation (TENS) machine and modified surface electrodes. Participants visited the laboratory once and received either active (200 μs, 30 Hz; n = 34) or sham (n = 14) stimulation. RESULTS: Active tVNS significantly increased HRV in healthy participants (P = 0.026) indicating a shift in cardiac autonomic function toward parasympathetic predominance. Microneurographic recordings revealed a significant decrease in frequency (P = 0.0001) and incidence (P = 0.0002) of muscle sympathetic nerve activity during tVNS. CONCLUSION: tVNS can increase HRV and reduce sympathetic nerve outflow, which is desirable in conditions characterized by enhanced sympathetic nerve activity, such as heart failure. tVNS can therefore influence human physiology and provide a simple and inexpensive alternative to invasive VNS.
BACKGROUND: Vagus nerve stimulation (VNS) is currently used to treat refractory epilepsy and is being investigated as a potential therapy for a range of conditions, including heart failure, tinnitus, obesity and Alzheimer's disease. However, the invasive nature and expense limits the use of VNS in patient populations and hinders the exploration of the mechanisms involved. OBJECTIVE: We investigated a non-invasive method of VNS through electrical stimulation of the auricular branch of the vagus nerve distributed to the skin of the ear--transcutaneous VNS (tVNS) and measured the autonomic effects. METHODS: The effects of tVNS parameters on autonomic function in 48 healthy participants were investigated using heart rate variability (HRV) and microneurography. tVNS was performed using a transcutaneous electrical nerve stimulation (TENS) machine and modified surface electrodes. Participants visited the laboratory once and received either active (200 μs, 30 Hz; n = 34) or sham (n = 14) stimulation. RESULTS: Active tVNS significantly increased HRV in healthy participants (P = 0.026) indicating a shift in cardiac autonomic function toward parasympathetic predominance. Microneurographic recordings revealed a significant decrease in frequency (P = 0.0001) and incidence (P = 0.0002) of muscle sympathetic nerve activity during tVNS. CONCLUSION:tVNS can increase HRV and reduce sympathetic nerve outflow, which is desirable in conditions characterized by enhanced sympathetic nerve activity, such as heart failure. tVNS can therefore influence human physiology and provide a simple and inexpensive alternative to invasive VNS.
Authors: Yuan Yuan; Jonathan L Hassel; Anisiia Doytchinova; David Adams; Keith C Wright; Chad Meshberger; Lan S Chen; Maria P Guerra; Changyu Shen; Shien-Fong Lin; Thomas H Everett; Vicenta Salanova; Peng-Sheng Chen Journal: Heart Rhythm Date: 2017-08-01 Impact factor: 6.343
Authors: Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis Journal: Exp Physiol Date: 2018-11-29 Impact factor: 2.969
Authors: Roberta Sclocco; Ronald G Garcia; Norman W Kettner; Kylie Isenburg; Harrison P Fisher; Catherine S Hubbard; Ilknur Ay; Jonathan R Polimeni; Jill Goldstein; Nikos Makris; Nicola Toschi; Riccardo Barbieri; Vitaly Napadow Journal: Brain Stimul Date: 2019-02-10 Impact factor: 8.955